The abstract contains NO quantitative statistics whatsoever. It describes a systematic review of 7 articles (5 case reports, 2 case series) with only 28 total patients. There is no mention of hazard ratios, confidence intervals, percentages, or any comparative analysis between COVID-19 patients and controls. The study is purely descriptive, noting that all 28 patients presented with hearing loss. The claimed HR 1.6 (95% CI: 1.2-2.1) and '+60%' figure appear completely fabricated - these are epidemiological measures that would require a cohort or case-control study design with control groups, which this systematic review of case reports does not provide. The abstract explicitly states the included studies were 'mainly case reports' with no control groups for comparison.

Suggested fix: The source is a systematic review of 7 descriptive studies (case reports/series) with 28 total patients. No comparative statistics vs. controls are provided. The claim should be removed or replaced with: 'Case series description: 28 COVID-19 patients with otologic dysfunction, all with hearing loss; no control group or comparative statistics available.'

The claim presents specific risk ratios (1.0, 2.1, 0.6) for persistent olfactory dysfunction by factor (hyposmia at onset, complete anosmia at onset, parosmia development). However, the abstract contains NO quantitative risk factor analysis whatsoever. The abstract only reports: (1) prevalence data at baseline (86.4% complete anosmia, 11.5% very severe loss), (2) recovery/improvement rates at 1-week follow-up (80.1% improved, 11.5% complete resolution, 17.3% persistent complete loss), and (3) cumulative improvement rate of 79%. There is no mention of risk ratios, odds ratios, hazard ratios, or any multivariate analysis of predictors for persistent dysfunction. The specific numbers 1.0, 2.1, and 0.6 do not appear anywhere in the abstract, nor does any analysis comparing hyposmia vs. anosmia as risk factors for persistence. The abstract does not mention 'parosmia' at all. This appears to be a fabricated statistic that may be conflating this paper with a different study, or completely invented.

The claim states '68%' with 'MRI abnormalities (95% CI: 54-80%)' but the abstract reports 91.3% for olfactory bulb signal intensity abnormalities, not 68%. The 68% figure does not appear anywhere in the abstract. Additionally, the abstract does not report any confidence intervals (95% CI: 54-80%) for any statistic. The claim appears to be a significant underreporting of the actual finding (91.3% vs 68%) and includes fabricated confidence intervals. The closest percentage to 68% in the abstract is 73.9% (olfactory cleft opacification on CT) or possibly a misreading of 60.9% (shallow olfactory sulci), but neither matches the claimed MRI abnormality statistic.

Suggested fix: Olfactory Bulb MRI signal intensity abnormalities: 91.3% (no CI reported in abstract). Note: Study population was 23 patients with persistent COVID-19 olfactory dysfunction (minimum 1-month duration), all anosmic at time of imaging. CT finding of olfactory cleft opacification was 73.9%.